arXiv.itsnick.co

an independent field guide to 23 million papers from arXiv & OpenAlex — not affiliated with arXiv.org

Author

Fengling Yu

2 papers · 2021–2023

2021: 12022: 02023: 1
2021peak 1 in 20212023

Frequent co-authors

Papers

showing 1–2 of 2 RSS

Person Re-Identification Based on Multi-Task Parallelism

Fengling Yu, Dan Yu

Computer Vision and Pattern Recognition · · cited 0× · DOI ↗ · more like this ·

Pedestrian re-identification technology is widely applied in the fields of pedestrian tracking, criminal investigation, and intelligent image classification. However, pedestrian images obtained from surveillance cameras often suffer from low resolution, lighting variations, visual blur, and complex backgrounds, making pedestrian re-identification challenging. To address these issues, this paper proposes a method that incorporates local branches and segmentation branches into the traditional global recognition framework to compensate for the lack of spatial information in global features and reduce the impact of low-quality images on recognition accuracy. Additionally, this paper applies the random erasing algorithm to alleviate the problem of network overfitting to specific prominent features. Experimental results demonstrate that the proposed method achieves high accuracy on multiple…

Promising Enzymes for Inhibitors Development Against COVID-19

Zhigang Sun, Fengling Yu, Xiangting Qiu +3 more

Computational Theory and Mathematics · Mini-Reviews in Medicinal Chemistry · · cited 0× · DOI ↗ · more like this ·

After the emergence of COVID-19 in 2019, it has now become a pandemic. COVID-19 has brought painful disasters to people all over the world. It not only threatens lives and health but also induces economic crises. At present, promising methods to eradicate COVID-19 mainly include drugs and vaccines. Enzyme inhibitors have always been a reliable strategy for the treatment of related diseases. Scientists worldwide have worked together to study COVID-19, obtained the structure of key SARS-CoV-2 associated enzymes, and reported the research of inhibitors of these enzymes. This article summarizes COVID-19-related enzyme inhibitors' recent development, mainly including 3CLpro, PLpro, TMPRSS2, and RdRp inhibitors, hoping to provide valuable weapons in the ensuing battle against COVID-19.